46

Yuan Qing

Pulmonology

About me

Yuan Qing, male, associate chief physician, associate professor, medical doctor, Young Member of the Anti-Infection Branch of Beijing Pharmacological Society.

1996.7-2001.7 Shanxi Medical University, Bachelor of Clinical Medicine.

2001.7-2004.7 Master's degree student in the Department of Infectious Diseases, Beijing Friendship Hospital, affiliated to Capital Medical University.

2004.7-2009.7 Resident physician in the Department of Critical Care Medicine, Beijing Friendship Hospital, affiliated to Capital Medical University.

2006.7-2009.7 Doctoral student in the field of infectious diseases and critical care medicine at Capital Medical University.

2009.7-2014.3 Beijing Century Hospital, Department of Respiratory Medicine.

2014.4-present Beijing Century Hospital, Cadre Medical Department.

He has received further training in respiratory critical care at China-Japan Friendship Hospital. Engaged in clinical, teaching, and research work on respiratory infectious diseases, respiratory critical conditions, respiratory endoscopy, Chronic Obstructive Pulmonary Disease (COPD), and asthma. Proficient in respiratory medicine, particularly in theoretical knowledge, new developments, new technologies, and clinical diagnosis and treatment in the mentioned areas. Principal investigator of 1 bureau-level research project and 3 internal projects at the hospital. Co-author of 2 specialized books, with over 20 research papers published at home and abroad, including 5 papers indexed by SCI.

Proficient in diseases

Respiratory system infections, asthma, respiratory failure, various difficult-to-treat diseases, and the diagnosis of thoracic imaging particularly in benign and malignant tumors!
voiceIcon

Voices

home-news-image
Written by Yuan Qing
Pulmonology
43sec home-news-image

What is Mycoplasma pneumoniae afraid of?

Mycoplasma pneumoniae is a relatively special microorganism, situated between bacteria and viruses. It is smaller than bacteria but larger than viruses. This type of mycoplasma can grow within bacterial cells through a filter. In such cases, clinically, we generally use specific medications to treat Mycoplasma pneumoniae. Typically, for respiratory infections caused by mycoplasma, we use macrolides or quinolones; for urinary tract infections, quinolones are usually the preferred treatment. Therefore, the medication choice should be based on the location of the infection. (Specific medications should be used under the guidance of a physician.)

home-news-image
Written by Yuan Qing
Pulmonology
53sec home-news-image

Is pneumoconiosis contagious?

Pneumoconiosis does not fall under the category of infectious diseases and is not contagious. Pneumoconiosis is primarily caused by the inhalation of large amounts of mineral dust containing selenium in living or production environments. This dust deposits in the alveoli and leads to disease. The disease is mainly due to the long-term stimulation of the lungs by dust in the alveoli, resulting in pulmonary fibrosis. Patients primarily exhibit symptoms of chronic cough, expectoration, and wheezing. Over time, complications such as pulmonary heart disease may also arise, making this a severe disease. However, this disease does not belong to the category of infectious diseases. It is mainly caused by exposure to inorganic dust in industrial and living environments, so it is not contagious, which is not a concern.

home-news-image
Written by Yuan Qing
Pulmonology
50sec home-news-image

What should I do about pleurisy calcification?

Pleural calcification, mainly results from long-term unresolved pleuritis or inadequate timely treatment, causing adherence between the two pleural layers. Following this adhesion, calcium salts may deposit, leading to calcification. Usually, the primary consideration is whether the patient's lung function has been impacted. If so, a thoracotomy and pleural decortication might be performed to restore the pleural structure. If the patient only shows pleural calcification on imaging without significant discomfort, it may be observed without immediate intervention, and regular monitoring of the calcification is recommended to see if it enlarges. If the condition remains stable over time, it might not require treatment since this represents a tendency towards healing, or the residual scarring may not necessitate special management.

home-news-image
Written by Yuan Qing
Pulmonology
44sec home-news-image

How to check for pneumoconiosis

Pneumoconiosis is primarily caused by inhaling a large amount of gases containing dust particles in our production or work environment. These gases deposit in our alveoli over a long period, leading to the retention of dust in the lungs. Subsequently, this dust irritates the alveoli and pulmonary interstitium, leading to pulmonary interstitial fibrosis. Patients may experience symptoms such as coughing, wheezing, and difficulty breathing. The examination of pneumoconiosis mainly relies on imaging of the chest, such as chest radiographs, combined with pulmonary function tests, which can essentially determine the diagnosis of pneumoconiosis and also assess the severity of the disease.

home-news-image
Written by Yuan Qing
Pulmonology
58sec home-news-image

Is it good to place a filter for pulmonary embolism or not?

Whether it is good or not to place a filter for pulmonary embolism mainly depends on the cause of the pulmonary embolism and whether there are indications for placing a filter. Generally speaking, if pulmonary embolism is caused by the formation of blood clots in the lower limbs or the inferior vena cava, placing a filter can generally be beneficial. However, not all cases of lower limb venous thrombosis require a filter. Filters are usually only used for deep or large vein thromboses that are not suitable for thrombectomy or thrombolysis treatments. If a filter is placed under other conditions, it is very likely that thrombosis will re-form on the surface of the filter, potentially leading to some recurrent pulmonary embolisms or iatrogenic pulmonary embolisms. Therefore, the decision to place a filter is complex and requires a doctor to weigh the pros and cons before deciding whether or not to proceed.

home-news-image
Written by Yuan Qing
Pulmonology
1min 7sec home-news-image

The difference between acute upper respiratory tract infection and acute pharyngitis

The difference between acute upper respiratory infection and acute pharyngitis is actually a matter of the scope and extension of a concept. An upper respiratory infection refers to infections occurring in the nose, pharynx, and throat, collectively known as the upper respiratory tract. If this area is infected by some pathogenic microorganisms, leading to symptoms such as nasal congestion, runny nose, cough, and sore throat, we call it an acute upper respiratory infection. Acute pharyngitis specifically refers to the occurrence of inflammation in the pharynx following an infection, primarily presenting with sore throat or cough. This condition is called acute pharyngitis. From this perspective, acute pharyngitis is actually a specific type of acute upper respiratory infection. The main focus is still on distinguishing these diseases, giving special attention where necessary, such as providing specific treatment for pharyngitis, whereas a general cold medicine might suffice for an upper respiratory infection. Thus, there are certain distinctions between the two.